CRDL
NASDAQ · Pharmaceuticals
Cardiol Therapeutics Inc-A
$1.88
+0.02 (+0.81%)
Open$1.88
Previous Close$1.86
Day High$1.98
Day Low$1.84
52W High$3.23
52W Low$1.23
Volume—
Avg Volume283.2K
Market Cap308.41M
P/E Ratio—
EPS$-0.34
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,194.9% upside
Current
$1.88
$1.88
Target
$24.28
$24.28
$16.80
$24.28 avg
$33.59
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.47M | 20.00M | 18.14M |
| Net Income | 5.10M | 5.20M | 4.96M |
| Profit Margin | 23.8% | 26.0% | 27.3% |
| EBITDA | 10.24M | 10.30M | 9.42M |
| Free Cash Flow | 5.58M | 6.38M | 6.16M |
| Rev Growth | +3.9% | -4.2% | -9.3% |
| Debt/Equity | 1.16 | 1.28 | 1.00 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,148.51 | -1.85% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $267.76 | -0.53% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $147.66 | -2.15% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.05 | +0.43% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.77 | -1.50% | 11.5 | 30.15B |